» Articles » PMID: 17591659

Ketamine Effects on CNS Responses Assessed with MEG/EEG in a Passive Auditory Sensory-gating Paradigm: an Attempt for Modelling Some Symptoms of Psychosis in Man

Overview
Publisher Sage Publications
Specialty Pharmacology
Date 2007 Jun 27
PMID 17591659
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Disturbances in integrative function have been consistentLy described in psychotic disorder; for instance, prepulse inhibition of the startle reflex (startle-PPI) which is a marker of sensory gating, is deficient in persons with schizophrenia. The N-methyl-D-aspartate antagonist ketamine produces in control subjects a spectrum of neurobehavioural symptoms like encountered in schizophrenia, and disrupts startle-PPI in animals. In the present study, we investigated in 12 healthy subjects whether ketamine would reduce sensory-gating in auditory responses at doses which produce psychotic symptoms. In a double-blind, crossover design loading doses of 0.024, 0.081 and 0.27 mg/kg or saline were employed, followed by maintenance infusion for 120 min. A passive paradigm has been developed which consisted in tone bursts, preceded or not by a (near-threshold) click at intervals of 100 ms or 500 ms. Brain electromagnetic activity imaging of the responses to sound stimuli has been carried out by way of a 148-channel magnetoencephalography-system. Actual evoked response amplitudes and underlying equivalent current dipole strengths have been compared to multi-electrode evoked potentials from the scalp. A click stimulus is capable to inhibit test responses under placebo at the 100 ms interval. During maintenance infusion of ketamine at steady-state (for >30 min) after 0.27 mg/kg, no such amplitude changes were observed anymore (p <0.05) and under these circumstances significant increases in Brief Psychiatric Rating scale and Scale for the Assessment of Negative Symptoms scores were evidenced (p < 0.001). Intermediate effects have been observed when the dose was lowered to 0.081 mg/kg. The present results have shown that ketamine may induce a psychotic-like clinical state associated with gating deficits in healthy subjects.

Citing Articles

N-methyl-D-aspartate receptor antagonism impairs sensory gating in the auditory cortex in response to speech stimuli.

de la Salle S, Choueiry J, McIntosh J, Bowers H, Ilivitsky V, Knott V Psychopharmacology (Berl). 2022; 239(7):2155-2169.

PMID: 35348805 DOI: 10.1007/s00213-022-06090-z.


Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.

Beck K, Hindley G, Borgan F, Ginestet C, McCutcheon R, Brugger S JAMA Netw Open. 2020; 3(5):e204693.

PMID: 32437573 PMC: 7243091. DOI: 10.1001/jamanetworkopen.2020.4693.


Potential Mechanisms for the Ketamine-Induced Reduction of P3b Amplitudes.

Rosburg T, Schmidt A Front Behav Neurosci. 2019; 12:308.

PMID: 30618662 PMC: 6297878. DOI: 10.3389/fnbeh.2018.00308.


Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.

Haaf M, Leicht G, Curic S, Mulert C Curr Pharm Biotechnol. 2018; 19(4):293-307.

PMID: 29929462 PMC: 6142413. DOI: 10.2174/1389201019666180620112528.


A putative electrophysiological biomarker of auditory sensory memory encoding is sensitive to pharmacological alterations of excitatory/inhibitory balance in male macaque monkeys.

Holliday W, Gurnsey K, Sweet R, Teichert T J Psychiatry Neurosci. 2018; 43(3):182-193.

PMID: 29688874 PMC: 5915239.